• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthpublic health

Ohio’s Attorney General Is Suing 5 Drug Makers for Fueling the Opioid Epidemic

By
Sy Mukherjee
Sy Mukherjee
By
Sy Mukherjee
Sy Mukherjee
June 1, 2017, 5:04 AM ET

Ohio Attorney General Mike DeWine is suing five pharmaceutical companies for their alleged part in driving an opioid and prescription painkiller overdose epidemic which has ravaged the state and much of the country. The firms named in the suit are Purdue Pharma, Johnson & Johnson, Teva, Allergan, and Endo International.

DeWine says that the companies’ aggressive marketing tactics effectively placed “profits above health and well-being of Ohio consumers,” and that the drug makers were aware that their claims about the powerful medicines’ addictive capacity were misleading.

Click hereto subscribe to Brainstorm Health Daily, our brand new newsletter about health innovations.

“The evidence is going to show they knew what they were saying was not true and they did it to increase sales,” DeWine told a press pool.

Purdue Pharma, the manufacturer of OxyContin, and other defendants have already faced legal scrutiny over the opioid scourge which has claimed hundreds of thousands of lives over the past decade. Orange County and New York jurisdictions have also sued painkiller firms in recent months over alleged fraudulent marketing.

Purdue and other opioid manufacturers say they are committed to solving the addiction and overdose crisis. According to the Columbus Dispatch, more than 4,100 Ohio residents died from unintentional drug overdoses last year alone, a 36% spike over 2015.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.